Ann Humphreys, B.Sc., Mba Email & Phone Number

Toronto, Canada Area

An international consultancy focused on Precision Medicine. The company was formed to consult with and support companies for the launch of Precision Medicines and their companion diagnostics. Precision Rx-Dx supports their multidisciplinary (medical, marketing, access) clients to tailor and refine global strategies for optimal local/regional implementation. Their objective is to support clients to build local market and organizational readiness to ensure a robust launch and accelerated adoption of both the targeted therapeutic and the associated companion or complementary diagnostic. Precision Rx-Dx has extensive knowledge of the biomarker and companion diagnostic landscape in the local markets it serves. The Precision team is very familiar with the rapidly evolving biomarker and diagnostic policies and practices in these local markets and works closely with a deep network of influential multidisciplinary stakeholders.The core team at Precision Rx-Dx Inc. are senior professionals with strong expertise in both diagnostic and pharmaceutical development and diverse capabilities to plan and implement a full range of programs specifically for Precision Medicine and Companion Diagnostics.

Toronto, Canada Area

Advise and support healthcare companies; in both therapeutic, diagnostic and medical device categories on their market development, launch and growth strategies including Key Opinion Leader and Stakeholder development and engagement.

Reporting to the President and member of the Management Board and Board of Directors, with strategic involvement across Janssen-Ortho’s complete product portfolio. Led the fastest growing business unit, which included the Biotechnology, Oncology, Pain and Wound Healing products. Managed a staff of 120 to achieve 25% plus annual growth over a five-year period. Responsible for the corporate New Product Development group and the launch of all new therapeutic products.

Toronto, Ontario

Reported to the President and member of the Management Board and Board of Directors. Led the Biotech business unit and the corporate Business Development function. Managed a staff of 25; generated sales revenues of $43MM.

Toronto, Ontario

Reported to VP, Corporate Development. Responsible for the creation and on-going management of the $30MM Biotechnology business unit and its 20 employees.Identified the business opportunity and obtained approval for a new unit to develop the company’s biotechnology product franchise. Created an innovative team approach in sales and marketing, the “business/franchise unit” structure, which was then used across the organization. Implemented the organizational plan, hired the management group and the sales force. Championed and led the cross-functional development and launch in Canada of J&J’s largest product EPREX, creating a new model for hospital/specialty product launches. Anticipated the need, planned and implemented a pioneering program to lobby government, in collaboration with healthcare and patient stakeholders, to provide incremental funding for this breakthrough product. In contrast to other biotech products, government funding was established in all major markets within three months of approval. This resulted in fast adoption of EPREX by the medical community and stakeholders and sales of $8MM in the first ten months.Championed an extensive pioneering clinical research program, which established the Canadian Nephrology community’s reputation worldwide. Supported a compassionate use program resulting in 4% of all patients being on therapy before launch and accelerated early adoption.

Toronto, Ontario

Responsible for strategic planning/forecasting and market development for the company’s new pharmaceutical and biotech product portfolio. Launched new products in diverse areas including a home pregnancy test and the company’s first biotechnology product, ORTHOCLONE OKT3, a monoclonal antibody for transplantation. Achieved market leadership position within one year.

Toronto, Ontario

Progressed from the position of Technical Sales Representative to Product Manager, Specialty Diagnostics (1979 – 1980) to Product Manager, New Products (1980 – 1984). Responsible for working with the Canadian research group on the development and launch of new diagnostic products developed in Canada. Co-ordinated support for the approval and launch of these products in international markets, including the U.S. market

Mba, Majored In Marketing & International Business, Honour Roll

B.Sc., Nutrition, First Class Honours, First In Class